Intellia Therapeutics Investors
![](/files/companies/Intellia%20Therapeutics.png)
Intellia Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2014 The company specializes in developing innovative gene-editing therapies using CRISPR technology to address various genetic diseases Intellia has raised a total of $108 million in funding to support its research and development efforts With a strong focus on advancing its therapeutic pipeline, Intellia aims to transform the treatment landscape for patients with serious genetic disorders The company is committed to scientific excellence and collaboration within the biotechnology community
Investors
Connections from
Founded Date:
2014
Last Funding Type:
Post-IPO Equity
Headquarters:
USA
Investors Number:
9
Employee Number:
251-500
Industry:
FemTech
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-06-30
Funding Status:
IPO
Investor Type:
Angel Groups
Total Funding:
775000000